MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

CUSIP: 62855J104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93,057,750
Total 13F shares
89,898,458
Share change
+7,148,226
Total reported value
$1,720,778,542
Put/Call ratio
42%
Price per share
$19.14
Number of holders
193
Value change
+$139,092,939
Number of buys
99
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 62855J104?
CUSIP 62855J104 identifies MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2023

As of 31 Dec 2023, MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 89,898,458 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, GLENVIEW CAPITAL MANAGEMENT, LLC, STATE STREET CORP, EARNEST PARTNERS LLC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and DIMENSIONAL FUND ADVISORS LP. This page lists 193 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.